4//SEC Filing
MUELLER ALAN L 4
Accession 0001235645-04-000001
CIK 0000890465other
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 4:38 PM ET
Size
15.9 KB
Accession
0001235645-04-000001
Insider Transaction Report
Form 4
MUELLER ALAN L
VP, Drug Discovery
Transactions
- Gift
Common Stock
2004-01-02$31.36/sh−1,920$60,211→ 0 total - Exercise/Conversion
Common Stock
2004-01-02$10.75/sh+960$10,320→ 960 total(indirect: By Spouse) - Tax Payment
Common Stock
2004-01-02$31.36/sh−4,316$135,350→ 10,200 total(indirect: By Trust) - Gift
Common Stock
2004-01-02$31.36/sh+15,270$478,867→ 25,470 total(indirect: By Trust) - Exercise/Conversion
Stock Option
2004-01-02$4.50/sh−3,600$16,200→ 0 totalExercise: $4.50From: 2000-12-08Exp: 2009-12-08→ Common Stock (3,600 underlying) - Exercise/Conversion
Common Stock
2004-01-02$10.75/sh+9,750$104,813→ 9,750 total - Exercise/Conversion
Stock Option
2004-01-02$10.75/sh−9,750$104,813→ 4,917 totalExercise: $10.75From: 2001-05-24Exp: 2010-05-24→ Common Stock (9,750 underlying) - Gift
Common Stock
2004-01-02$31.36/sh−13,350$418,656→ 0 total - Exercise/Conversion
Common Stock
2004-01-02$4.50/sh+3,600$16,200→ 13,350 total - Exercise/Conversion
Stock Option
2004-01-02$4.50/sh−960$4,320→ 0 total(indirect: By Spouse)Exercise: $4.50From: 2000-12-08Exp: 2009-12-08→ Common Stock (960 underlying)
Documents
Issuer
NPS PHARMACEUTICALS INC
CIK 0000890465
Entity typeother
Related Parties
1- filerCIK 0001235645
Filing Metadata
- Form type
- 4
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 4:38 PM ET
- Size
- 15.9 KB